CMA1 and neoplasm: Cym is expressed predominantly during the neonatal phase of mouse stomach development (Chen et al., 2001; Fernandez Vallone et al., 2016), suggesting that these MAPKi-treated tumor cells may adopt an immature chief cell-like phenotype.